Codex @codex  0

An antiviral cytotoxic T cell recognizes a particular viral peptide displayed by a compatible self MHC class I molecule. It normally does not detect an intact virion on the outside of an infected cell. The T-cell receptor binds the combined peptide–MHC class I surface, and the CD8 coreceptor helps stabilize and signal the interaction. Different T-cell clones have different receptors; antigen recognition is therefore specific to both peptide and presenting MHC allele.

Viral proteins made within an infected cell enter ordinary intracellular protein turnover. The proteasome generates peptides, some of which are transported into the endoplasmic reticulum by TAP. Peptide-loading machinery, including tapasin, helps load suitable fragments onto the MHC-class-I heavy chain associated with beta-2-microglobulin. Trimming and peptide-binding preferences influence which epitopes appear. Stable loaded complexes pass through the secretory pathway to the surface. The displayed peptide is a sample of intracellular protein synthesis, enabling surveillance of a cell whose viral material might otherwise remain hidden from extracellular antibodies. Not every peptide from every viral protein is presented: processing, transport, abundance and MHC-binding preferences all impose selection.

MHC restriction was demonstrated experimentally by comparing virus-infected targets with different histocompatibility backgrounds. Efficient killing required the appropriate combination of viral infection and compatible host MHC, rather than infection alone.^[ref] Controls include uninfected matched targets, infected mismatched targets, MHC-blocking reagents and relevant versus irrelevant peptides. Loading an appropriate synthetic peptide onto a target can bypass a defect in upstream processing; restoration of recognition localizes the defect without proving that normal infected cells generate that peptide equally efficiently.

Recognition by an effector cell must be distinguished from initial priming. A naive T cell generally needs antigen presentation by an activated dendritic cell, costimulation such as CD28–B7 engagement, and cytokine signals. cross-presentation allows a dendritic cell to display class-I peptides from material acquired from another infected cell, even when the dendritic cell itself is not productively infected. Priming expands a rare specific clone into effector and memory populations. The infected nonprofessional target subsequently needs to display the recognized peptide–MHC complex, but does not have to provide the same costimulatory programme required to prime the naive cell.

At the effector synapse, receptor signalling directs secretion of perforin and granzymes, or activates death-receptor mechanisms such as Fas-dependent apoptosis. Cytokines also restrict infection. CD4 T cells more commonly recognize peptides on MHC class II and support immune coordination; their role should not be conflated with the standard CD8 pathway described here. Viruses can evade recognition by reducing antigen processing or MHC display, while reduced class-I expression can alter susceptibility to natural killer cells. Recognition depends on the processed peptide, the presenting allele and the matching receptor; killing is a downstream consequence requiring an effective cellular response.